On 7th September 2012 I attended The Spinal Research Reception Evening at Kings College, London. I attend this every year as I think it’s extremely important to keep updated with what’s new on the research front.
Dr. Mark Bacon who is the Director of Research, did a talk on The Future of Chronic Spinal Cord Injury Repair – A Focus on Chondroitinaise. Programme: http://www.spinal-research.org/wp-content/uploads/2012/11/Programme.pdf
Chondroitinaise is a bacterial enzyme which is able to digest scar tissue that impedes nerve regeneration and stifles changes needed for effective rehabilitation. Researchers are currently looking to modify this enzyme into a form that is safe for use in humans so that it can be taken into clinical trials. This has already shown fantastic results in which treated animal models have reduced scarring, preserved nerve function in the injury zone and demonstrated better recovery of normal movements. This treatment holds great promise and has generated much excitement in the scientific community.
About Spinal Research: http://www.spinal-research.org/about-us/